65 unrated drugs suspended, including caporitablets

[Dynamic Networkpharmaceutical industry] now, has been evaluated by the consistency is a prerequisite for drug purchasesMay 18, Liaoning Province, medicines and medical supplies centralized procurement network issued "on the part of the publicity about the drug suspended hanging procurement" (hereinafter referred to publicity)display publicity, according to "on the specification by the generic quality consistency and efficacy evaluation Drug screening procurement", of pharmaceuticals for the same (in terms specification) in Liaoning Province, hanging by purchasing quality and efficacy of generic drugs to evaluate the agreement has reached more than three (according to the new classification registered generic drugs deemed approved by the consistency of the quality and efficacy evaluation, included in the statistical range), other have not been hanging in Liaoning Province procurement Drug screening assessment suspend procurement of medicines not comment has not been hanging in Liaoning province of Liaoning Province temporarily into the scope of centralized procurementThe carding, Liaoning Province, the pharmaceutical suspension of hanging 65 total procurement, including finasteride tablets, captopril tablets, paracetamol tablets, metformin, triprolidine hydrochloride TMZ tablets, cetirizine tablets and other companies involved in the bidding Ren Tang pharmaceutical, Shijiazhuang pharmaceutical Holdings, North China pharmaceutical, the Shanghai pharmaceutical, American Shanghai Squibb, Franc Groupaddition, acetaminophen, finasteride tablets, captopril tablets 75, etcnot shown in Liaoning Province, not hanging over Review Drug temporarily into Liaoning Province centralized procurementLately, many provinces have not been released because the list of medicines comment to suspend the hanging net purchasesWhich only April, there Jiangsu, Shenzhen, Beijing and other places not suspended by the consistency of evaluation of products, the number of species in about 1000, involves nearly 600 companiesApril 17, Jiangsu issued "on the part of the public not to suspend procurement of quality and efficacy of generic drugs through consistent evaluation of drugs." Pause purchase amoxicillin, omeprazole enteric-coated capsules, escitalopram oxalate tablets, meloxicam tablets, sodium bicarbonate tablets, cephalexin capsules, tablets and other levetiracetam 152 medicines, including involving Medicines, on drugs, rock four-drug, North China pharmaceutical and other pharmaceutical companiessame day, Shenzhen and drug transaction platform suspended eight have not been consistent evaluation of drug procurement, involving atorvastatin calcium, amlodipine besylate tablets, amoxicillin, acetaminophen aminophenols tablets, metronidazole tablets, indapamide tabletsApril 13, Beijing issued "on the suspension of part of the notification does not pass the conformance assessment product procurement functions within the scope of the State Central Purchasing" shows that Beijing will not suspend procurement over 843 varieties of assessment, involving Kazakhstan Pharmaceutical shares part of the A-share listed companiesauthor notes, is suspended throughout the procurement list, captopril tablets and other varieties appear frequentlyStatistics show that captopril tablets is a product for the treatment of cardiovascular and cerebrovascular diseasesMeters within the network data show that in 2018 its sales in public medical institutions terminal China's 1.57 billionAt present, the major manufacturers, including Changzhou Pharmaceutical, Bristol-Myers Squibb, Fu Jen Catholic Pharmaceutical Group, Elohim Pharmaceutical, Shijiazhuang Pharmaceutical Europa medicine and so on, can be described as intense competition May 14, the State Food and Drug Administration officially released "State Food and Drug Administration announcement regarding the development of chemical injection drug quality and efficacy of generic consistency of evaluation work," which means that the consistency of the evaluation of drug injection Officially launched SFDA clear, consistent evaluation by species will be subject to the relevant policy support: The breed consistency in evaluation, drug regulatory authorities allowing it to be marked on the instructions and labels, and their integration into the "new generic drugs approved for marketing as well as through quality consistency and efficacy evaluation of chemicals directory set " Industry analysts believe that with the advance of a series of policy, the future will form a national drug Jicai "1 + 3" pattern - one plus three original drug by evaluating the consistency of generic drugs, and there are more appropriate assessment of competing products had not been temporarily excluded from public hospitals, the country 500 billion generics market reshuffle will be intensified In this context, the industry is expected, there will be 90% of the generics out of the market, industry concentration will be further enhanced, without consistency evaluation by generics will accelerate out of the market, in the hospital to suspend procurement.